SMLV | VTWO | SMLV / VTWO | |
Gain YTD | -7.177 | -14.166 | 51% |
Net Assets | 191M | 11.9B | 2% |
Total Expense Ratio | 0.12 | 0.07 | 171% |
Turnover | 56.00 | 12.00 | 467% |
Yield | 3.03 | 1.43 | 211% |
Fund Existence | 12 years | 15 years | - |
SMLV | VTWO | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | 2 days ago88% |
Stochastic ODDS (%) | 2 days ago83% | 2 days ago83% |
Momentum ODDS (%) | 2 days ago78% | 2 days ago82% |
MACD ODDS (%) | 2 days ago83% | 2 days ago90% |
TrendWeek ODDS (%) | 2 days ago81% | 2 days ago84% |
TrendMonth ODDS (%) | 2 days ago78% | 2 days ago84% |
Advances ODDS (%) | 3 days ago84% | 19 days ago88% |
Declines ODDS (%) | 8 days ago79% | 5 days ago85% |
BollingerBands ODDS (%) | 2 days ago84% | 2 days ago88% |
Aroon ODDS (%) | 2 days ago73% | 2 days ago85% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BUI | 22.72 | -0.02 | -0.07% |
BlackRock Utilities Infrastructure & Power Opportunities Trust | |||
HYXF | 45.80 | -0.43 | -0.93% |
iShares ESG Advanced Hi Yld Corp Bd ETF | |||
GDV | 23.38 | -0.99 | -4.06% |
Gabelli Dividend & Income Trust (The) | |||
SPXE | 57.88 | -2.88 | -4.74% |
ProShares S&P 500® ex-Energy | |||
CNCR | 8.92 | -0.46 | -4.90% |
Range Cancer Therapeutics ETF |
A.I.dvisor indicates that over the last year, SMLV has been closely correlated with FMBH. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMLV jumps, then FMBH could also see price increases.
Ticker / NAME | Correlation To SMLV | 1D Price Change % | ||
---|---|---|---|---|
SMLV | 100% | -5.09% | ||
FMBH - SMLV | 91% Closely correlated | -7.87% | ||
MCBS - SMLV | 90% Closely correlated | -7.11% | ||
BFC - SMLV | 88% Closely correlated | -5.51% | ||
NIC - SMLV | 88% Closely correlated | -6.78% | ||
OBK - SMLV | 86% Closely correlated | -8.57% | ||
More |